Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,405
Closed -$2.34M 376
2025
Q1
$2.34M Buy
22,405
+1,450
+7% +$181K 0.12% 121
2024
Q4
$2.83M Buy
20,955
+1,734
+9% +$249K 0.15% 111
2024
Q3
$3M Buy
19,221
+959
+5% +$143K 0.15% 111
2024
Q2
$2.7M Buy
18,262
+1,092
+6% +$172K 0.15% 113
2024
Q1
$3.04M Sell
17,170
-4,273
-20% -$650K 0.18% 98
2023
Q4
$3.05M Buy
+21,443
New +$2.62M 0.19% 84
2019
Q1
Sell
-8,432
Closed -$557K 161
2018
Q4
$557K Sell
8,432
-428
-5% -$32.9K 0.07% 84
2018
Q3
$782K Sell
8,860
-1,116
-11% -$92.8K 0.1% 70
2018
Q2
$759K Sell
9,976
-227
-2% -$16.7K 0.1% 58
2018
Q1
$708K Buy
10,203
+1,464
+17% +$107K 0.1% 57
2017
Q4
$570K Buy
+8,739
New +$528K 0.09% 68

Other funds holding TGT

Trilogy Capital's TGT Position: Q2 2025 in Review

Trilogy Capital sold out of Target (TGT) in Q2 2025, closing a stake of 22,405 shares — an estimated $2.34M sold.

Trilogy Capital first reported a position in TGT in Q4 2017 and held it in 11 quarters. The position peaked at $3.05M in Q4 2023. 1,754 funds tracked by Wall St. Rank hold TGT as of Q2 2025.

  • Trilogy Capital reported no remaining Target position as of Q2 2025 after selling out during the quarter.
  • Trilogy Capital sold 22,405 Target shares in Q2 2025, an estimated $2.34M.
  • Trilogy Capital first reported a position in Target in Q4 2017 and held it in 11 quarters.
  • Trilogy Capital's Target position peaked at $3.05M in Q4 2023.
  • 1,754 funds tracked by Wall St. Rank held Target as of Q2 2025.

Based on Trilogy Capital's 13F filing for Q2 2025, filed 18 Jul 2025.